跳至主要内容
临床试验/NCT00796380
NCT00796380Unknown4 期

Clinical Study of Xingnaojing for the Treatment of Convulsive Diseases

Shenzhen Children's Hospital0 个研究点目标入组 1 人开始时间: 2008年12月最近更新:
适应症
相关药物

试验速览

阶段
4 期
入组人数
1
主要终点
Frequency of convulsive episodes

研究概览

简要总结

The purpose of this study is to evaluate the efficacy of Xingnaojing for the treatment of convulsive diseases; to investigate whether convulsion episodes can be induced or aggravated by Xingnaojing and the role inflammation plays in the process.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
1 Month 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Febrile convulsion: positive family history of febrile convulsion; aged between 6 months and 6 years old; in accordance with the diagnosis criteria of simple type of febrile convulsion
  • Frequent episodes of epilepsy: epilepsy episodes of all types; > 3 times / week
  • Refractory epilepsy: no satisfactory efficacy after treatment by 2~3 antiepileptic drugs; ≥ 1 time / month
  • Cerebral palsy: all types of cerebral palsy in children less than 3 years old. -

排除标准

  • Febrile convulsion: family history of epilepsy, complex type of febrile convulsion, epileptic episodes, febrile convulsion plus
  • Frequent episodes of epilepsy: combined with advanced diseases
  • Refractory epilepsy: epilepsy combined with advanced diseases
  • Cerebral palsy: advanced diseases combined with backwardness or retardation of brain function development.

结局指标

主要结局

Frequency of convulsive episodes

时间窗: 1 year

Antipyretic rate , Frequency of convulsive episodes ,

时间窗: one year

次要结局

未报告次要终点

研究者

申办方类型
Other Gov

相似试验